Actionable Molecular Alterations Are Revealed in Majority of Advanced Non-Small Cell Lung Cancer Patients by Genomic Tumor Profiling at Progression after First Line Treatment

por Frank, Malene Støchkel, Bodtger, Uffe, Gehl, Julie, Ahlborn, Lise Barlebo
Publicado 2021